PMID: 15373222Sep 18, 2004Paper

Regenerative medicine in cardiology

Nihon Geka Gakkai zasshi
Tomohiro Manabe, K Fukuda

Abstract

Emerging evidence indicates that cardiomyocytes can be regenerated from embryonic stem cells, adult mesenchymal stem cells, and cardiac side population cells (cardiac stem cells). When these cells were injected into diseased hearts, indices of cardiac function improved. There are ethical difficulties involved in the use of embryonic stem cells. The ratio of differentiation into cardiomyocytes is still relatively low at present. Transplantation of regenerated cardiomyocytes or stem cells, however, will become a future therapy for severe heart failure.

Related Concepts

Related Feeds

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Regenerative Medicine
Annarosa LeriPiero Anversa
Nihon rinsho. Japanese journal of clinical medicine
Masayoshi Kinoshita, K Fukuda
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
T WangYuan Du
Nihon rinsho. Japanese journal of clinical medicine
Takayuki Morisaki, Kyoko Hidaka
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
K Fukuda
© 2021 Meta ULC. All rights reserved